Skip to content

Study of Retinal Vascular Parameters in Patients With Wilson's Disease

Study of Retinal Vascular Parameters in Patients With Wilson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04408300
Acronym
WILLY
Enrollment
124
Registered
2020-05-29
Start date
2020-06-04
Completion date
2022-02-15
Last updated
2022-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wilson Disease

Keywords

Optical Coherence Tomography, Adaptive optics

Brief summary

The rare disease reference center Wilson disease and other rare copper-related diseases of the Rothschild Foundation follows a large number of patients with Wilson's with varying degrees of impairment and located at different times of their care. Many people with Wilson's disease have a characteristic greenish-brown ring, known as Kayser-Fleischer, appearing at the periphery of the cornea due to a deposit of copper at the Descemet membrane. As a general rule, if the patient is compliant with his treatment, the ring usually disappears within a few years, although it may persist in some patients. However, apart from the stage of diagnosis, and the evolution of the ring, ophthalmological examinations are little used for the follow-up of these patients. The objective of this study is to describe the retinal parameters, in particular vascular with two new retinal imaging technologies (OCT-A :Optical Coherence Tomography-Angiography , Adaptive optics) in patients with Wilson's disease and to correlate them with the parameters of the usual follow-up of these patients (hepatic assessment, exchangeable plasma copper, neurological scores, compliance, etc.).

Interventions

Retinophotography, OCT-A (Optical Coherence Tomography- Angiography), OCT-B scan (Optical Coherence Tomography B Scan), Measurement of corrected visual acuity in ETDRS (Early Treatment Diabetic Retinopathy Study), Measurement of intraocular pressure, adaptive optics

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Wilson's disease with Ferenci score ≥4

Exclusion criteria

* Neurological or behavioral handicap that does not allow for ophthalmological examinations * Hepatic decompensation that does not allow for ophthalmological examinations * Pregnant or breastfeeding woman

Design outcomes

Primary

MeasureTime frameDescription
Measurement of the capillary density of the deep plexus (in%)EnrollmentOCT-A
Measuring the width of the Kayser-Fleischer ringEnrollmentOCT-B scan
Corrected visual acuity measurementEnrollmentETDRS
Intraocular pressure measurement (mmHg)Enrollment
Measurement of the thickness of the retinal nerve fibers layer (RNFL)EnrollmentOCT-B
Measurement of the central avascular zone (in µm2)InclusionOCT-A
Measurement of the capillary density of the superficial plexus (in%)EnrollmentOCT-A
Measurement of photoreceptor density (per mm2)EnrollmentAdaptive optics
Measurement of wall to lumen ratio (in %)EnrollmentAdaptive optics
Measurement of the arterial wall section area (µm²)EnrollmentAdaptive optics
Measurement of the diameter of the arterial lumen (µm)EnrollmentAdaptive optics

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026